glp-1 gastric intestinal obstruction legal team in kentucky class action law office glp -1 digestive blockage kentucky Pharmaceutical giant Novo Nordisk is – glp-1 gastric intestinal obstruction law

[Accessed on 11 June 2026] Oral semaglutide 50 mg taken once per day in adults with overweight or obesity (OASIS 1): a randomised, double-blind, placebo-controlled, phase 3 trial (2023)

The data showed a modestly reduced risk of depression with GLP-1RAs when compared with DPP4is and a negligible difference in depression risk between GLP-1RAs and SGLT2is

The gut-brain axis at work @jclinicalinvest jci.org/articles/view/ important finding for refining GLP-1 drugs and reducing the side effects in the future This is relevant to eating disorders

Women who once spent every waking hour calculating meals or battling food cravings suddenly reclaim enormous amounts of mental space

A.BergmanA.StevensC.KoteyP.YiB.ZhaoP.et al (2006a)